Complete with business, health management, and oncology tracks, sessions at the National Association of Managed Care Physicians (NAMCP) Spring Managed Care Forum will focus on a variety of topics.
The National Association of Managed Care Physicians Forum (NAMCP) Spring Managed Care Forum will kick-off this week with in-person sessions taking place in Orlando, Florida, on April 21-22.
Complete with business, health management, and oncology tracks, sessions will focus on a variety of topics, spanning health care consolidation to new developments in the treatment of heart failure.
Experts representing both health plans and university medical centers are slated to speak, with Dexter Shurney, MD, chief medical officer of Adventist Health, scheduled to deliver the keynote address “Food As Medicine” on Thursday April 21.
“It’s always a great time when I’m at NAMCP,” Shurney said in an interview with The American Journal of Managed Care® (AJMC®). “I just want to raise awareness, I want to show people the power of food as I have learned for myself,” he said, adding that his talk will focus on how individuals can better incorporate diet decisions into their own personal lives.
Value-based care will also serve as a running theme throughout the forum, with sessions including “Strengthening Payer Relations Within Value-Based Care Arrangements” and “Transitioning Providers From Fee-For-Service to Value-Based Contracts" taking place.
Additional talks will highlight updates in disease management and new therapeutic advancements for conditions like pulmonary arterial hypertension, acute myeloid leukemia, non–small cell lung cancer, and inflammatory bowel disease, among others.
On the financial side, Business Track sessions include presentations on preventing patients from becoming super-users and aligning physician groups to maximize managed care performance.
The conference, which takes place in the spring and fall each year, is a joint endeavor of the American Association of Integrated Healthcare Delivery Systems, the American Association of Managed Care Nurses, and the NAMCP Medical Directors Institute.
Previous iterations have included presentations on overcoming hurdles to promote biosimilar uptake in oncology and examining social determinants of health in a commercially insured health care workplace.
According to the host organizations, objectives for the NAMCP Spring Forum include providing attendees with:
Continuing education opportunities will also be available for attendees.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
In VERIFY, Rusfertide Spares Most Patients With PV a Phlebotomy for 32 Weeks, Improves QOL
June 3rd 2025Adding rusfertide to standard of care more than doubled the share of patients with polycythemia vera (PV) who did not meet criteria for a phlebotomy, according to data from the VERIFY trial.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Depth of Responses, PFS in Transplant-Ineligible Patients Match Overall Findings in CEPHEUS
June 2nd 2025Quadruplet therapy is now the accepted standard for patients newly diagnosed with myeloma who are ineligible for transplant; there is debate whether all newly diagnosed patients should have this regimen.
Read More
Trastuzumab Deruxtecan Plus Pertuzumab Improves PFS vs Standard Care in HER2+ Breast Cancer
June 2nd 2025Trastuzumab deruxtecan plus pertuzumab demonstrated statistically and clinically significant improvement in progression-free survival (PFS) in HER2-positive breast cancer, potentially representing a new standard of care.
Read More